1. Home
  2. SNDX vs SPB Comparison

SNDX vs SPB Comparison

Compare SNDX & SPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Syndax Pharmaceuticals Inc.

SNDX

Syndax Pharmaceuticals Inc.

HOLD

Current Price

$21.21

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Spectrum Brands Holdings Inc.

SPB

Spectrum Brands Holdings Inc.

HOLD

Current Price

$60.13

Market Cap

1.4B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNDX
SPB
Founded
2005
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
SNDX
SPB
Price
$21.21
$60.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
4
Target Price
$36.92
$83.50
AVG Volume (30 Days)
1.6M
281.7K
Earning Date
11-03-2025
02-05-2026
Dividend Yield
N/A
3.13%
EPS Growth
N/A
N/A
EPS
N/A
3.86
Revenue
$111,304,000.00
$2,809,000,000.00
Revenue This Year
$620.14
$1.64
Revenue Next Year
$115.42
$1.47
P/E Ratio
N/A
$15.60
Revenue Growth
595.65
N/A
52 Week Low
$8.58
$49.99
52 Week High
$22.73
$87.23

Technical Indicators

Market Signals
Indicator
SNDX
SPB
Relative Strength Index (RSI) 64.62 55.36
Support Level $19.72 $59.15
Resistance Level $22.73 $60.81
Average True Range (ATR) 0.91 1.76
MACD -0.05 -0.19
Stochastic Oscillator 59.94 58.84

Price Performance

Historical Comparison
SNDX
SPB

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

About SPB Spectrum Brands Holdings Inc.

Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.

Share on Social Networks: